Review: taking Metoprolol tartrate and Pravastatin sodium together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Pravastatin sodium together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Pravastatin sodium. It is created by eHealthMe based on reports of 2,279 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol tartrate and Pravastatin sodium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 38,992 users)

Pravastatin Sodium

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. (latest outcomes from Pravastatin sodium 8,439 users)

On Jul, 24, 2016

2,279 people who take Metoprolol Tartrate, Pravastatin Sodium are studied.


Number of reports submitted per year:

Metoprolol tartrate and Pravastatin sodium drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 46.0% - (7 of 15 people)
  • 6 - 12 months: 33.0% - (3 of 9 people)
  • 1 - 2 years: 6.0% - (3 of 43 people)
  • 2 - 5 years: 50.0% - (20 of 40 people)
  • 5 - 10 years: 55.0% - (5 of 9 people)
  • 10+ years: 81.0% - (9 of 11 people)
  • not specified: 100.0% - (1 of 1 people)
Pravastatin Sodium:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 60.0% - (21 of 35 people)
  • 6 - 12 months: 33.0% - (4 of 12 people)
  • 1 - 2 years: 29.0% - (8 of 27 people)
  • 2 - 5 years: 38.0% - (12 of 31 people)
  • 5 - 10 years: 8.0% - (1 of 12 people)
  • 10+ years: 50.0% - (2 of 4 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 29.0% - (23 of 77 people)
  • male: 49.0% - (25 of 51 people)
Pravastatin Sodium:
  • female: 50.0% - (38 of 76 people)
  • male: 25.0% - (12 of 47 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 44.0% - (4 of 9 people)
  • 50-59: 33.0% - (12 of 36 people)
  • 60+: 37.0% - (30 of 81 people)
Pravastatin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 11.0% - (1 of 9 people)
  • 50-59: 14.0% - (5 of 34 people)
  • 60+: 53.0% - (42 of 78 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • asthenia
  • dyspnoea
  • oedema peripheral
  • fatigue
  • decreased appetite
  • dysarthria
  • hypotension
  • rash pruritic
  • bradycardia
1 - 6 months:
  • acquired afibrinogenaemia
  • cardiomegaly
  • chest pain
  • renal failure
  • ventricular tachycardia
  • anaemia
  • asthenia
  • pancreatitis acute
  • thrombocytopenia
  • weight decreased
6 - 12 months:
  • febrile neutropenia
  • fever
  • abnormal dreams
  • anxiety
  • blood pressure fluctuation
  • burning feet syndrome
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • feeling of despair
  • headache - tension
  • malaise
1 - 2 years:
  • acquired afibrinogenaemia
  • shortness of breath
  • anxiety
  • benign prostatic hyperplasia
  • bursitis
  • dermatitis contact
  • intervertebral disc protrusion
  • nervous system disorder
  • concussion
  • fall
2 - 5 years:
  • dizziness
  • myocardial infarction
  • anxiety
  • diarrhea associated with medications
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • mental status - decreased
  • muscle weakness
  • vision problems
  • fatigue
  • confusion
5 - 10 years:
  • weight gain
  • blood creatine phosphokinase increased
  • hypotension
  • malaise
  • myalgia
  • myocardial infarction
  • tooth decay
  • abdominal pain
  • alopecia
  • arm and leg movements - uncontrollable
10+ years:
  • depression
  • fatigue
  • myocardial infarction
  • angina unstable
  • anxiety
  • bronchitis
  • chest pain
  • coronary artery disease
  • dental caries
  • diabetes mellitus
not specified:
  • pain
  • fatigue
  • dyspnoea
  • nausea
  • myocardial infarction
  • anaemia
  • pleural effusion
  • chest pain
  • dizziness
  • hypotension

Most common drug interactions by gender *:

female:
  • pain
  • fatigue
  • anaemia
  • pleural effusion
  • rectal haemorrhage
  • nausea
  • haemorrhoids
  • cystitis
  • cardioactive drug level increased
  • colonic polyp
male:
  • dyspnoea
  • myocardial infarction
  • nausea
  • hypotension
  • dizziness
  • fatigue
  • anxiety
  • asthenia
  • pain
  • injury

Most common drug interactions by age *:

20-29:
  • blood creatinine increased
  • diabetes mellitus
  • kidney transplant rejection
  • lymphocele
  • type 2 diabetes mellitus
  • wound dehiscence
30-39:
  • hypotension
  • pain
  • pain in extremity
  • oedema peripheral
  • myocardial infarction
  • arthralgia
  • atrophy
  • chest pain
  • gait disturbance
  • joint contracture
40-49:
  • chest pain
  • fatigue
  • myocardial infarction
  • nausea
  • cardiac failure congestive
  • pain
  • injury
  • dyspnoea
  • coronary artery disease
  • anxiety
50-59:
  • myocardial infarction
  • nausea
  • pain
  • anxiety
  • chest pain
  • dyspnoea
  • oedema peripheral
  • fatigue
  • cardiac failure congestive
  • pain in extremity
60+:
  • fatigue
  • pain
  • dyspnoea
  • pleural effusion
  • anaemia
  • nausea
  • rectal haemorrhage
  • haemorrhoids
  • dizziness
  • myocardial infarction

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Pravastatin sodium?

Can you answer these questions?

More questions for: Metoprolol tartrate, Pravastatin sodium

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Pravastatin sodium

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Pravastatin sodium (pravastatin sodium) is often used to treat high blood cholesterol. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.